<SEC-DOCUMENT>0000849146-16-000188.txt : 20160913
<SEC-HEADER>0000849146-16-000188.hdr.sgml : 20160913
<ACCEPTANCE-DATETIME>20160913163039
ACCESSION NUMBER:		0000849146-16-000188
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20160913
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20160913
DATE AS OF CHANGE:		20160913

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lifevantage Corp
		CENTRAL INDEX KEY:			0000849146
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		IRS NUMBER:				841097796
		STATE OF INCORPORATION:			CO
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-35647
		FILM NUMBER:		161883140

	BUSINESS ADDRESS:	
		STREET 1:		9785 S. MONROE STREET
		STREET 2:		SUITE 300
		CITY:			SANDY
		STATE:			UT
		ZIP:			84070
		BUSINESS PHONE:		801-432-9000

	MAIL ADDRESS:	
		STREET 1:		9785 S. MONROE STREET
		STREET 2:		SUITE 300
		CITY:			SANDY
		STATE:			UT
		ZIP:			84070

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LIFELINE THERAPEUTICS, INC.
		DATE OF NAME CHANGE:	20041019

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	YAAK RIVER RESOURCES INC
		DATE OF NAME CHANGE:	19920703

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	ANDRAPLEX CORP
		DATE OF NAME CHANGE:	19920406
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>form8-kpressrelease9x13x16.htm
<DESCRIPTION>8-K
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2016 Workiva -->
		<title>Document</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s5C5D062636C5BD8E57F520A8F189CAE2"></a></div><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><div><br></div><div style="line-height:144%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">UNITED STATES</font></div><div style="line-height:144%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">SECURITIES AND EXCHANGE COMMISSION</font></div><div style="line-height:144%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Washington, D.C. 20549</font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:144%;text-align:center;font-size:18pt;"><font style="font-family:inherit;font-size:18pt;font-weight:bold;">FORM 8-K</font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:center;font-size:14pt;"><font style="font-family:inherit;font-size:14pt;font-weight:bold;">CURRENT REPORT</font></div><div style="line-height:144%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Pursuant to Section&#160;13 or 15(d) of the Securities Exchange Act of 1934</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:center;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;font-weight:bold;">Date of Report (Date of earliest event reported): September 13, 2016</font></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:9pt;">&#160;</font><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:120%;font-size:24pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td><td style="width:20%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-top:2px;text-align:center;padding-left:2px;font-size:24pt;"><font style="font-family:inherit;font-size:24pt;font-weight:bold;">LIFEVANTAGE CORPORATION</font></div><div style="padding-bottom:2px;padding-top:2px;text-align:center;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">(Exact name of registrant as specified in its charter)</font></div></td></tr></table></div></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">______________________________</font><font style="font-family:inherit;font-size:9pt;">&#160;</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="5"></td></tr><tr><td style="width:31%;"></td><td style="width:7%;"></td><td style="width:27%;"></td><td style="width:7%;"></td><td style="width:28%;"></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Colorado</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">001-35647</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">90-0224471</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(State or other Jurisdiction of Incorporation)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Commission File Number)</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(IRS Employer Identification No.)</font></div></td></tr><tr><td colspan="3" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">9785 S. Monroe Street, Suite 300, Sandy, UT 84070</font></div></td></tr><tr><td colspan="5" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:2px;font-size:8pt;"><font style="font-family:inherit;font-size:8pt;font-weight:bold;">(Address of Principal Executive Offices and Zip Code)</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td colspan="5" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:center;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">Registrant&#8217;s telephone number, including area code: (801)&#160;432-9000</font></div></td></tr></table></div></div><div style="line-height:144%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">______________________________</font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:144%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:3%;"></td><td style="width:97%;"></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-(b))</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;font-size:10pt;"><font style="font-family:Wingdings;font-size:10pt;">o</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman; font-size:10pt;"><tr><td style="width:96px;"></td><td></td></tr><tr><td style="vertical-align:top"><div style="line-height:120%;font-size:10pt;padding-left:0px;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">Item 8.01.</font></div></td><td style="vertical-align:top;"><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">Other Events.</font></div></td></tr></table><div style="line-height:120%;text-align:left;padding-left:96px;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">&#160;&#160;&#160;&#160;</font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">On September 13, 2016, LifeVantage Corporation (the &#8220;Company&#8221;) issued a press release announcing a delay in the release of its fourth quarter and fiscal year 2016 financial results and Form 10-K filing. A copy of the Company&#8217;s press release is attached as Exhibit 99.1 to this report and incorporated herein by reference.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;background-color:#ffffff;font-weight:bold;">Item 9.01.&#160;&#160;&#160;&#160;Financial Statements and Exhibits.</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:110%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">(d)&#160;&#160;&#160;&#160;Exhibits</font></div><div style="line-height:110%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="4"></td></tr><tr><td style="width:12%;"></td><td style="width:1%;"></td><td style="width:3%;"></td><td style="width:84%;"></td></tr><tr><td colspan="2" style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Exhibit No.</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;text-decoration:underline;">Description</font></div><div style="padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:right;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">99.1</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="text-align:left;padding-left:4px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Press release dated September 13, 2016</font></div></td></tr></table></div></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div><br></div><div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:left;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div></div><div><br></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:center;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;font-weight:bold;">SIGNATURE</font></div><div style="line-height:120%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="line-height:120%;text-align:left;text-indent:48px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.</font></div><div style="line-height:120%;font-size:10pt;"><div style="padding-left:0px;text-indent:0px;line-height:normal;padding-top:10px;"><table cellpadding="0" cellspacing="0" style="font-family:Times New Roman;font-size:10pt;width:100%;border-collapse:collapse;text-align:left;"><tr><td colspan="2"></td></tr><tr><td style="width:50%;"></td><td style="width:50%;"></td></tr><tr><td colspan="2" style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td><td style="vertical-align:bottom;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="overflow:hidden;height:18px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#160;</font></div></td></tr><tr><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;text-align:left;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Date: September 13, 2016</font></div></td><td style="vertical-align:top;padding-left:2px;padding-top:2px;padding-bottom:2px;padding-right:2px;"><div style="padding-bottom:2px;padding-top:2px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">LIFEVANTAGE CORPORATION</font></div><div style="padding-bottom:2px;padding-top:2px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;"><br></font></div><div style="padding-bottom:2px;padding-top:2px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">By: </font><font style="font-family:inherit;font-size:10pt;text-decoration:underline;">/s/ Beatryx Washington</font></div><div style="padding-bottom:2px;padding-top:2px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Name:  Beatryx Washington</font></div><div style="padding-bottom:2px;padding-top:2px;padding-left:2px;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">Title:  Senior Vice President Legal Affairs</font></div></td></tr></table></div></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div style="line-height:120%;font-size:12pt;"><font style="font-family:inherit;font-size:12pt;"><br></font></div><div><br></div><div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>lfvn_09-13x16xpressrelease.htm
<DESCRIPTION>EXHIBIT 99.1
<TEXT>
<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01 Transitional//EN" "http://www.w3.org/TR/html4/loose.dtd">
<html>
	<head>
		<!-- Document created using Wdesk 1 -->
		<!-- Copyright 2016 Workiva -->
		<title>Exhibit</title>
	</head>
	<body style="font-family:Times New Roman;font-size:10pt;">
<div><a name="s7BF2A506A0AC16E2D9FB24FA77CCC3B0"></a></div><div><div style="line-height:120%;text-align:center;"><img src="lfvnq42016earningsrel_image2.jpg" alt="lfvnq42016earningsrel_image2.jpg" style="height:62px;width:213px;"></div></div><div><br></div><div style="line-height:138%;text-align:center;font-size:14pt;"><font style="font-family:Arial;font-size:14pt;"><br></font></div><div style="line-height:138%;text-align:center;font-size:14pt;"><font style="font-family:Arial;font-size:14pt;font-weight:bold;">LifeVantage Announces Delay in the Release of its Fourth Quarter and Fiscal Year 2016 Financial Results and Form 10-K Filing</font></div><div style="line-height:138%;text-align:center;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">Salt Lake City, UT,</font><font style="font-family:Arial;font-size:12pt;">&#32;</font><font style="font-family:Arial;font-size:12pt;font-weight:bold;">September 13, 2016</font><font style="font-family:Arial;font-size:12pt;">, LifeVantage Corporation (NASDAQ: LFVN) today announced that it will delay the release of its fourth quarter and fiscal year 2016 financial results. Following an internal review by Company personnel of its policies and procedures, the Company is in the process of reviewing its sales into certain international markets and the revenue and income tax accruals associated with such sales. The Company is currently unable to estimate the impact of the review to net revenue, tax expense, net income or other aspects of its financial statements for the fiscal year ended June 30, 2016 or any potential prior periods. The Audit Committee of the Company's Board of Directors is conducting an independent review of these matters and has retained independent counsel to assist in that review. </font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">The review relates to sales of the Company&#8217;s products in certain international markets and the determination of revenue and the deductibility of commission and incentive expenses associated with such sales, as well as the policies and procedures related to sales in those specific markets. The Company will experience a delay in the timely filing of its Annual Report on Form 10-K for its fiscal year ended June 30, 2016 (the "Form 10-K") and expects to file a notification of late filing on Form 12b-25 with the Securities and Exchange Commission to obtain an automatic 15-day extension of the filing deadline for the Form 10-K. &#160;There can be no assurance that the Company will complete the preparation and filing of the Form 10-K within the extension period.</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">LifeVantage President and Chief Executive Officer Darren Jensen stated, &#8220;We regularly review our policies and procedures to ensure the utmost accuracy and transparency in our financial reporting. Our Board&#8217;s Audit Committee has engaged independent external resources to review our policies and procedures and support our team in finalizing our financial results for fiscal 2016.&#8221;</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;">The Company will not be in a position to release financial results for the fiscal year ended June 30, 2016 until the independent review by the Audit Committee is completed. The Company is working diligently on this matter and will, as soon as practicable, make a further announcement regarding the updated timing of the release of financial results and a conference call on its financial results. &#160;</font></div><div style="line-height:138%;text-align:justify;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">About LifeVantage Corporation</font></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:13pt;"><font style="font-family:Arial;font-size:13pt;">LifeVantage Corporation (Nasdaq:LFVN) is a science based network marketing company dedicated to visionary science that looks to transform health, wellness and anti-aging internally and externally at the cellular level. The Company is the maker of </font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div><hr style="page-break-after:always"><div><div style="line-height:120%;text-align:center;"><img src="lfvnq42016earningsrel_image2.jpg" alt="lfvnq42016earningsrel_image2.jpg" style="height:62px;width:213px;"></div></div><div><br></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:13pt;"><font style="font-family:Arial;font-size:13pt;">Protandim</font><font style="font-family:Arial;font-size:13pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></font><font style="font-family:Arial;font-size:13pt;">&#32;Nrf2 and NRF1 Synergizers, our line of scientifically-validated dietary supplements, the TrueScience</font><font style="font-family:Arial;font-size:13pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></font><font style="font-family:Arial;font-size:13pt;">&#32;Anti-Aging Skin Care Regimen, Canine Health</font><font style="font-family:Arial;font-size:13pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></font><font style="font-family:Arial;font-size:13pt;">, the AXIO</font><font style="font-family:Arial;font-size:13pt;"><sup style="vertical-align:top;line-height:120%;font-size:pt">&#174;</sup></font><font style="font-family:Arial;font-size:13pt;">&#32;energy product line and the PhysIQ&#8482; smart weight management system. LifeVantage was founded in 2003 and is headquartered in Salt Lake City, Utah.</font></div><div style="line-height:138%;padding-bottom:13px;text-align:left;font-size:13pt;"><font style="font-family:Arial;font-size:13pt;"><br></font></div><div style="line-height:138%;padding-top:8px;text-align:left;font-size:12pt;"><font style="font-family:Arial;font-size:12pt;font-weight:bold;">Forward Looking Statements</font></div><div style="line-height:138%;text-align:left;font-size:9pt;"><font style="font-family:Arial;font-size:9pt;">This document contains forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Words and expressions reflecting optimism, satisfaction or disappointment with current prospects, as well as words such as "believe", "hopes", "intends", "estimates", "expects", "projects", "plans", "anticipates", "look forward to", "goal", &#8220;may be&#8221; "ideal fit", and variations thereof, identify forward-looking statements, but their absence does not mean that a statement is not forward-looking. Examples of forward-looking statements include, but are not limited to, statements we make regarding the conduct of our business in international markets, the independent review being conducted by the Audit Committee of our Board of Directors and the timing of our release of earnings information and the filing of our Form 10-K. Such forward-looking statements are not guarantees of performance and the Company's actual results could differ materially from those contained in such statements. These forward-looking statements are based on the Company's current expectations and beliefs concerning future events affecting the Company and involve known and unknown risks and uncertainties that may cause the Company's actual results or outcomes to be materially different from those anticipated and discussed herein. These risks and uncertainties include, among others, the final conclusions of the Audit Committee (and the timing of such conclusions) concerning the matters discussed above, including tax or other implications resulting from any accounting adjustments or other factors, and those discussed in greater detail in the Company's Annual Report on Form 10-K and the Company's Quarterly Report on Form 10-Q under the caption "Risk Factors," and in other documents filed by the Company from time to time with the Securities and Exchange Commission. The Company cautions investors not to place undue reliance on the forward-looking statements contained in this document. All forward-looking statements are based on information currently available to the Company on the date hereof, and the Company undertakes no obligation to revise or update these forward-looking statements to reflect events or circumstances after the date of this document, except as required by law. </font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;font-weight:bold;">Investor Relations Contact:</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:Arial;font-size:10pt;">Cindy England </font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Director of Investor Relations</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(801) 432-9036</font><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:Arial;font-size:10pt;">investor@lifevantage.com</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">&#32;<br>-or-</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:inherit;font-size:10pt;">&#32;<br></font><font style="font-family:Arial;font-size:10pt;">Scott Van Winkle </font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">Managing Director, ICR </font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">(617) 956-6736</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;">scott.vanwinkle@icrinc.com</font></div><div style="line-height:138%;text-align:left;font-size:10pt;"><font style="font-family:Arial;font-size:10pt;"><br></font></div><div><br></div><div><div style="line-height:120%;text-align:left;font-size:11pt;"><font style="font-family:inherit;font-size:11pt;"><br></font></div></div>	</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>lfvnq42016earningsrel_image2.jpg
<TEXT>
begin 644 lfvnq42016earningsrel_image2.jpg
M_]C_X  02D9)1@ ! 0$ > !X  #_VP!#  @&!@<&!0@'!P<)"0@*#!0-# L+
M#!D2$P\4'1H?'AT:'!P@)"XG("(L(QP<*#<I+# Q-#0T'R<Y/3@R/"XS-#+_
MVP!# 0D)"0P+#!@-#1@R(1PA,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C(R
M,C(R,C(R,C(R,C(R,C(R,C(R,C(R,C+_P  1" #I Q@# 2(  A$! Q$!_\0
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M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
M"BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH *
M*** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HH
MHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBDR/6@!:*** "BBB@ HHHH **** "B
MBB@ HHHR* "BDR/6EH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB
M@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH ****
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M=,^(EU$RIJ4"SIW>+Y6'X=#^E&J?$"]34)5T[[.]K\NQGC.[[HSGD<YS6/\
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M;"&SBV]-SGEF/N:TJX*V:S;M35D>QA\@@HWK.[/(KCP-KENFY8(YQC)\I_\
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M^?7N*][^E>/>-?\ D;K[ZI_Z+6O8R[$U)R=.3NK'S6=8&E2BJU-6;9ZIH_\
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MWTBP2TMUPBCDGJQ[D^]7N3WI8G'3J/EAI$O!973HKGJ^])]Q$C2-0JH%4#
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MY($6->>^,G^>/PKT#PG8+I_ARTCVX>11*_'\3<\_R_"O+O$9)\2:AG_GNP_
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M_P"@E-^8_P */^$IUS_H)3?F/\*X_P"RZG\R/3_MZC_*SVJDKQ;_ (2G7/\
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M]?+?^@K79UQ?PX_Y 5S_ -?+?^@K79UXV+_CR]3Z3+O]UAZ"T445SG:%%%%
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M "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH
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LH **** "BBB@ HHHH **** "BBB@ HHHH **** "BBB@ HHHH **** /_]D!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
